Cancer Patients and Researchers Challenge FDA Recommended Immunotherapy Dosing

By Arthur Allen · KFF Health News · 2026-08-20

According to KFF Health News, a growing coalition of medical professionals and patients is questioning the necessity of standard dosing for expensive cancer treatments like Opdivo and Keytruda. These advocates argue that the current protocols often lead to severe, life-altering s

According to KFF Health News, a growing coalition of medical professionals and patients is questioning the necessity of standard dosing for expensive cancer treatments like Opdivo and Keytruda. These advocates argue that the current protocols often lead to severe, life-altering s